New Study Explores Market Pipeline Analysis of Salivary Gland Cancer in H2 2016
Summary
Chemo drugs such as gemcitabine, capecitabine and oxaliplatin are now being tested for clinical trials and may provide more options for people with advanced salivary gland cancer.MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.The guide also covers the descriptive pharmacological action of the therapeutics on the basis of complete research & development history, latest news and press releases from company/ university sites.Request for Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=873472Initially, report provides a snapshot of the global therapeutic landscape of Salivary Gland Cancer with its overview, stages of developments, molecule type, pipeline products and drug profiles.Chemo drugs such as gemcitabine, capecitabine and oxaliplatin are now being tested for clinical trials and may provide more options for people with advanced salivary gland cancer.It includes:Cellular Immunotherapy for OncologyEntrectinibLOXO-101PembrolizumabTipifarnibTLC-388PexidartinibRegorafenibVaccine to Target WT1 for OncologyThe pipeline guide reviews key companies involved in Salivary Gland Cancer (Oncology) therapeutics developments and enlists all their major and minor projects.